Long-acting insulin analogue therapy initiation and follow-up by healthcare practitioners in patients with type 2 diabetes mellitus uncontrolled with oral antidiabetic drugs: the LIGHT Study

被引：0
|
作者：
Verges, B. [1 ]
Brun, J. -M. [1 ]
Tawil, C.
Alexandre, B. [2 ]
Kerlan, V. [3 ]
机构：
[1] CHU Dijon, Hop Bocage, Serv Endocrinol, Paris, France
[2] Novo Nordisk Pharmaceut, Med Affairs, Paris, France
[3] CHU La Cavale Blanche, Brest, France
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
972
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [21] Study of potential interactions of oral antidiabetic drugs in patients with type 2 diabetes mellitus with comorbidities: A retrospective study
    Utami, Primanitha Ria
    Octavia, Devi Ristian
    PHARMACY EDUCATION, 2022, 22 (02): : 200 - 206
  • [22] Healthcare utilisation and costs following initiation of insulin treatment in type 2 diabetes: a long-term follow-up in clinical practice
    Kalkan, A.
    Bodegard, J.
    Sundstrom, J.
    Svennblad, B.
    Ostgren, C.
    Nilsson, P. M.
    Johansson, G.
    Ekman, M.
    DIABETOLOGIA, 2015, 58 : S482 - S483
  • [23] Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional Insulin therapy in type 2 diabetes mellitus
    Lechleitner, M
    Roden, M
    Haehling, E
    Mueller, M
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (17) : 593 - 598
  • [24] The efficacy of long-term insulin glargine and oral antidiabetic therapy in patients with type 2 diabetes
    Schreiber, S
    Schneider, K
    Schweitzer, MA
    DIABETES, 2005, 54 : A143 - A143
  • [25] Effectiveness and Safety of Initiation and Titration of Insulin Glargine 300 U/mL in Insulin-Naive Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetic Drug Treatment in Turkey: The EASE Study
    Cetinarslan, Berrin
    Cetinkalp, Sevki
    Kaya, Ahmet
    Ersoy, Canan
    Kebapci, Nur
    Comlekci, Abdurrahman
    Tutuncu, Neslihan Bascil
    Deyneli, Oguzhan
    Oguz, Aytekin
    Ilkova, Hasan
    Yilmaz, Temel
    Hekimsoy, Zeliha
    Unubol, Mustafa
    Balci, Mustafa Kemal
    Atmaca, Ayseguel
    Dagdelen, Selcuk
    Yetkin, Ilhan
    Guler, Serdar
    Otunc, Goektuerk
    Ozhan, Leyla
    ENDOCRINOLOGY RESEARCH AND PRACTICE, 2024, 28 (01): : 4 - 11
  • [26] A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes
    Chun-Ting Yang
    Kuan-Ying Li
    Chen-Yi Yang
    Huang-Tz Ou
    Shihchen Kuo
    Scientific Reports, 11
  • [27] A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes
    Yang, Chun-Ting
    Li, Kuan-Ying
    Yang, Chen-Yi
    Ou, Huang-Tz
    Kuo, Shihchen
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] Direct healthcare costs and clinical outcomes after insulin initiation in patients with type 2 diabetes mellitus in Spain: 24-month follow-up data from the INSTIGATE study
    Dilla, Tatiana
    Nicolay, Claudia
    Alvarez, Maria
    Reviriego, Jesus
    Goday, Alberto
    Castell, Conxa
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (05): : 224 - 234
  • [29] Assess the efficacy differences of using long-acting insulin and oral hypoglycemic agents in type 2 diabetes patients
    Chen, Chiu-Ju
    Su, Hui-Chen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S98 - S98
  • [30] Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice
    Kalkan, Almina
    Bodegard, Johan
    Sundstrom, Johan
    Svennblad, Boa
    Ostgren, Carl Johan
    Nilsson, Peter Nilsson
    Johansson, Gunnar
    Ekman, Manias
    PRIMARY CARE DIABETES, 2017, 11 (02) : 184 - 192
12345